Cancer Meds in 2015: A Year in Review
This year was a big one for cancer treatment.
New Rx Treats Common Skin Cancer Type
A newly approved drug may fight one of the most common types of skin cancer.
New Skin Cancer Rx Gets Green Light
On July 24, 2015, the U. S. Food and Drug Administration approved sonidegib (Odomzo Capsules, Novartis Pharmaceuticals Corporation) for the treatment of patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.
Sunglasses: Looking Cooler and Staying Healthier
Sunglasses can do more than make you look like a movie star — they can also help protect your eyes from the sun's harmful rays.
Indoor Tanning Fades, but Millions Still Risk It
At one time, many people thought indoor tanning meant a healthy glow year-round. Today, more and more people may be realizing that this isn’t so.
ED Rx: A Possible Downside
While medications for erectile dysfunction can improve men's lives, they may also carry a downside.
Melanoma Rates on the Rise
After a long winter, you may be itching to head to the pool and bake in the sun. But don't grab your towel and sunglasses just yet. You may want to stay aware of the potential risks.
New Numbers on America's Most Common Cancer
The sun's rays may give you that healthy glow — but below the surface, there may be serious health risks.
Some Skin Cancers Saw Spike
As awareness about the dangers of sun exposure and skin cancer rises, the hope is that skin cancer rates will decrease. New evidence, however, suggests that rates may not be on the decline.
Pain and Itch May Indicate Skin Cancer
Dermatologists use a number of observational and laboratory methods to evaluate suspicious skin marks when looking for cancer. But a new study suggests simply asking a patient to evaluate itchiness or pain can help doctors make informed decisions.